Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2011-07-09 | NuQ™ and NuQ-X™ tests | prospective study | VolitionRX (Singapore) - Rheinische Friedrich-Wilhelms-Universität Bonn (Bonn University - Germany) | Cancer - Oncology | |
2011-07-07 | Multaq® (dronedarone) | permanent atrial fibrillation | 3 | Sanofi (France) | Cardiovascular diseases |
2011-07-07 | Zaltrap® (aflibercept) | hormone-refractory metastatic prostate cancer |
3 | Regeneron Pharmaceutical (USA) Sanofi (France) | Cancer - Oncology |
2011-07-07 | AXL1717 | solid tumors | 1-2 | Axelar (Sweden) | Cancer - Oncology |
2011-07-05 | OPN-305 | prevention of Delayed Graft Function (DGF) following renal transplantation |
1 | Opsona Therapeutics (Ireland) | Transplantation - Renal diseases - Kidney diseases |
2011-06-30 | talactoferrin | severe sepsis | 2-3 | Agennix (Germany) | Infectious diseases |
2011-06-29 | NVA237 (glycopyrronium bromide) | chronic obstructive pulmonary disease (COPD) |
3 | Novartis (Switzerland) | Respiratory diseases |
2011-06-29 | safinamide | Parkinson's disease |
3 | Merck Serono, a Merck KGaA company (Germany) Newron Pharmaceuticals (Italy) | Neurodegenerative diseases - CNS diseases |
2011-06-29 | ALX-0651 (anti-CXCR4 Nanobody) | stem cell mobilisation |
1 | Ablynx (Belgium) | |
2011-06-28 | mipomersen | heterozygous familial hypercholesterolemia |
3 | Genzyme (USA - MA), a Sanofi company (France) | Cardiovascular diseases - Genetic diseases - Rare diseases |
2011-06-28 | Trisomy 21 Diagnostic Test (LifeCodexx PraenaTest™) | Trisomy 21 (Down's syndrome) |
validation study | GATC Biotech (Germany) LifeCodexx (Germany) | Genetic diseases |
2011-06-27 | Ery-asp®/Graspa® (eryaspase - L-asparaginase loaded erythrocytes) | pancreatic cancer | 1 | Erytech (France) | Cancer - Oncology |
2011-06-23 | Diamyd® antigen based therapy | diabetes | 3 | Diamyd (Sweden) | Autoimmune diseases - Metabolic diseases |
2011-06-22 | LT-02 | ulcerative colitis |
2b | Lipid Therapeutics (Germany) | Inflammatory diseases - Autoimmune diseases |
2011-06-22 | EP217609 + avidin | management of coagulation during open-heart surgery | 2a | Endotis Pharma (France) | Cardiovascular diseases |
2011-06-22 | TMC649128 | Genotype-1 Hepatitis C Virus infection | 1b | Medivir (Sweden) Tibotec Pharmaceuticals (J&J Group - USA) | Infectious diseases |
2011-06-20 | vismodegib (RG3616/GDC-0449) | advanced basal cell carcinoma | 2 | Roche (Switzerland) | Cancer - Oncology |
2011-06-16 | PRC-4016 | mixed dyslipidemia | Pronova BioPharma (Norway) | Cardiovascular diseases | |
2011-06-15 | nalmefene | alcohol dependence | 3 | Lundbeck (Denmark) | CNS diseases |
2011-06-13 | masitinib | canine atopic dermatitis |
3 | AB Science(France) | Veterinary diseases |